Association of the CTLA4 3′ untranslated region polymorphism with the susceptibility to rheumatoid arthritis

被引:51
作者
Rodríguez, MR [1 ]
Núñez-Roldán, A [1 ]
Aguilar, F [1 ]
Valenzuela, A [1 ]
García, A [1 ]
González-Escribano, MF [1 ]
机构
[1] Univ Sevilla, Hosp Vergen Rocio, Serv Inmunol, Serv Andaluz Salud, Seville 41013, Spain
关键词
CTLA4; rheumatoid arthritis; genetic susceptibility; genetic polymorphism;
D O I
10.1016/S0198-8859(01)00358-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic T-lymphocyte antigen 4 (CTLA4) gene polymorphism located in the 3' untranslated region (UTR) was investigated in 141 Spanish patients (38 men and 103 women) with rheumatoid arthritis (RA) and in 194 ethnically-matched healthy controls. Twenty alleles having different numbers of (AT) repeats (from 7 to 32) were found in this population. (AT)(7) and (AT)(16) were the most frequent alleles, and accounted for almost two-thirds of the allelic frequency in the control population. Consequently, alleles were assigned as L (large: 16 or more AT repeats) or S (short: less than 16 AT repeats). When the US distribution in patients and controls were compared, an increase of L alleles was observed among patients (49.9%, vs. 39.7%; p = 0.02; p(c) = 0.04, odds ratio [OR] = 1.46; 95% confidence interval [CI], 1.06-2.01). Hence, the frequency of S alleles was decreased among patients (51.1% vs. 60.3%;p = 0.02;p(c) = 0.04; OR = 0.69; 95%CI, 0.50-0.95). Moreover, a statistically significant decrease in the frequency of S/S individuals was observed among RA patients (27.7% versus 40.7%; p = 0.01; p, = 0.03; OR = 0.56; 95%CI, 0.34-0.91). These differences were irrespective of the HLA "shared epitope" (SE) status, arid were observed similarly among SE+ as well as among SE- patients. After combining these data with other reported previously by us, from studies of CTLA4 49 (A/G) and -318 (C/T) polymorphisms, we conclude that the strongest association between CTLA4 gene polymorphisms and RA susceptibility occurs with the 3' UTR polymorphism. (C) American Society for Histocompatibility and Immunogenetics, 2002. Published by Elsevier Science Inc.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 36 条
[1]   Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population [J].
Ahmed, S ;
Ihara, K ;
Kanemitsu, S ;
Nakashima, H ;
Otsuka, T ;
Tsuzaka, K ;
Takeuchi, T ;
Hara, T .
RHEUMATOLOGY, 2001, 40 (06) :662-667
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis [J].
Barton, A ;
Myerscough, A ;
John, S ;
Gonzalez-Gay, M ;
Ollier, W ;
Worthington, J .
RHEUMATOLOGY, 2000, 39 (01) :63-66
[4]   Complex association analysis of Graves disease using a set of polymorphic markers [J].
Chistyakov, DA ;
Savost'anov, KV ;
Turakulov, RI ;
Petunina, NA ;
Trukhina, LV ;
Kudinova, AV ;
Balabolkin, MI ;
Nosikov, VV .
MOLECULAR GENETICS AND METABOLISM, 2000, 70 (03) :214-218
[5]   An Mse I RFLP in the human CTLA4 promotor [J].
Deichmann, K ;
Heinzmann, A ;
Bruggenolte, E ;
Forster, J ;
Kuehr, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :817-818
[6]   THE FAMILIAL NATURE OF RHEUMATOID-ARTHRITIS [J].
DEIGHTON, CM ;
WALKER, DJ .
ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (01) :62-65
[7]   Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease [J].
Donner, H ;
Braun, J ;
Seidl, C ;
Rau, H ;
Finke, R ;
Ventz, M ;
Walfish, PG ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4130-4132
[8]   CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [J].
Donner, H ;
Rau, H ;
Walfish, PG ;
Braun, J ;
Siegmund, T ;
Finke, R ;
Herwig, J ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :143-146
[9]   CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families [J].
Donner, H ;
Seidl, C ;
Braun, J ;
Siegmund, T ;
Herwig, J ;
Seifried, E ;
Usadel, KH ;
Badenhoop, K .
DIABETES, 1998, 47 (07) :1158-1160
[10]   CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis [J].
Gonzalez-Escribano, MF ;
Rodriguez, R ;
Valenzuela, A ;
Garcia, A ;
Garcia-Lozano, JR ;
Nuñez-Roldan, A .
TISSUE ANTIGENS, 1999, 53 (03) :296-300